NIFTY23,4170.05%
SENSEX74,3600.02%
BANKNIFTY54,3080.22%
NIFTY IT29,3010.29%
PHARMA24,1780.38%
AUTO26,1440.20%
FMCG48,2160.19%
METAL13,4360.73%
REALTY764.600.26%
ENERGY40,4460.62%
NIFTY23,4170.05%
SENSEX74,3600.02%
BANKNIFTY54,3080.22%
NIFTY IT29,3010.29%
PHARMA24,1780.38%
AUTO26,1440.20%
FMCG48,2160.19%
METAL13,4360.73%
REALTY764.600.26%
ENERGY40,4460.62%

Hedge Fund Managers Gather in Montreal to Pitch Next Big Thing

Hedge fund managers and other investors are gathered at the Sohn Montreal investment conference, where they are pitching the next big thing. The conference has seen presentations on a range of topics, including artificial intelligence, biotech, and gold mining.

At the conference, Whale Rock Capital Management LLC founder and chief executive officer Alex Sacerdote made a prediction about Anthropic PBC, stating that he expects the company to be headed towards half a billion users. Sacerdote noted that Anthropic has jumped from 2 million users to 14 million daily active users quickly, and that the company has a significant runway for growth. Whale Rock was a "significant investor" in Anthropic's Series G round earlier this year.

CompanyUsers (millions)Growth
Anthropic PBC1412x
Claude chatbot2-

Read also: Wall Street Ends Higher, Dow Reaches New Closing High

Sacerdote also highlighted the potential of Anthropic's Claude chatbot, stating that the company is "so early" in its development and that the first three years of AI were like a search engine "on steroids." He noted that the real prize is the enterprise market, which has not yet started to adopt AI.

StemPoint Capital LP pitched French biotech company Abivax SA as a potential M&A target. Chief Investment Officer and Managing Partner Michelle Ross noted that Abivax's drug obefazimod can be compared to Humira as a treatment that could be a "pipeline in a product for another company." Abivax shares plunged earlier this week after cancer cases in a crucial clinical trial for a bowel disease drug threw the French biotech's future into question. However, the stock was up as much as 16% Thursday in Paris on analysts saying the concerns over the trial were overdone.

Gold mining was another area of focus at the conference, with Toronto-based hedge fund Waratah Capital pitching Artemis Gold Inc. The mining company operates the Blackwater mine in British Columbia and has a long runway of growth, according to Brad Dunkley, chief investment officer and co-founder at Waratah. Dunkley noted that Artemis trades at a discount to comparable Canadian gold producers, despite having a large-scale asset in a top-tier jurisdiction, low operating costs, and fully funded growth.

CompanyCurrent Valuation MultiplePotential Upside
Artemis Gold Inc.10x50%

Read also: Stocks to Watch: Aurobindo Pharma, Panacea Biotec, InterGlobe Aviation, CG Power Industrial, AvenuesAI Under Scrutiny on June 5

Dunkley added that the company's Blackwater mine combines three attributes that are rarely found together: a large-scale asset in a top-tier jurisdiction, low operating costs, and fully funded growth. He estimated that the mine could generate more than C$2 billion (US$1.4 billion) of annual free cash flow by 2029, while a re-rating toward peer valuation multiples could deliver upside of more than 50% from current levels.

Anthropic confidentially submitted draft paperwork for a public listing on Monday, potentially leapfrogging longtime rival OpenAI in the race toward a Wall Street debut as soon as this fall. Despite concerns that soaring valuations have created an AI bubble, Sacerdote dismissed comparisons to the dot-com era, noting that today's AI leaders are generating substantial profits and trade at far lower multiples.

The biggest threat to the sector is not economics but regulation, Sacerdote added, warning that governments could slow innovation if public fears surrounding AI translate into restrictive policies. He noted that Americans "don't seem to like AI" and that there is a lot of "not in my backyard" sentiment, but that this will not be able to stop the trend.

Private credit was also a topic of discussion at the conference, with Third Point's head of private credit, Christopher Taylor, arguing that the asset class remains strong. Taylor noted that concentration risk is a product of how platforms were built, not an indictment of the asset class itself, and that diversification among borrowers adds protection.

Country view Pembroke Management Ltd.'s founder and chair Jeffrey Tory noted that Canada has "lost its status among investors" due to significant outflows of capital over the last decade, which have led to compressed valuations and higher cost of capital. However, this has created a "Made in Canada" discount in many industries, which provides a greater margin of safety and opportunity.

Pembroke's founder and chair Jeffrey Tory also highlighted the potential of Calgary-based Black Diamond Group Ltd., which specializes in workforce accommodation and modular spaces in remote areas such as Alberta's oil sands. The company stands to benefit from demand in resources and higher spending in infrastructure, Tory said.

Yacov Arnopolin, a managing director and portfolio manager for emerging markets at Pacific Investment Management Company LLC, pitched a trade in Nigerian treasury bills. He noted that Africa's most populous country has "huge potential" as a large oil producer and a stable and appreciating currency in the naira. However, he acknowledged that the country has security risks with terrorism in the north.

Investor Takeaway

Investors are optimistic about the growth potential of AI and biotech companies, with some predicting significant user adoption in the coming years.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.